Safeguard Scientifics (NYSE:SFE) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Safeguard Scientifics (NYSE:SFEFree Report) in a research note released on Sunday. The firm issued a hold rating on the asset manager’s stock.

Safeguard Scientifics Stock Performance

NYSE SFE opened at $0.46 on Friday. The company has a market capitalization of $7.54 million, a P/E ratio of -0.71 and a beta of 0.95. Safeguard Scientifics has a one year low of $0.40 and a one year high of $3.25. The stock has a 50 day moving average price of $0.37 and a 200-day moving average price of $0.13.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. First Manhattan Co. raised its holdings in Safeguard Scientifics by 1.5% during the 1st quarter. First Manhattan Co. now owns 992,316 shares of the asset manager’s stock valued at $5,179,000 after buying an additional 14,260 shares during the period. EJF Capital LLC raised its holdings in Safeguard Scientifics by 5.6% during the 1st quarter. EJF Capital LLC now owns 172,955 shares of the asset manager’s stock valued at $903,000 after buying an additional 9,151 shares during the period. Clayton Partners LLC increased its stake in Safeguard Scientifics by 15.7% in the first quarter. Clayton Partners LLC now owns 143,349 shares of the asset manager’s stock worth $247,000 after purchasing an additional 19,429 shares during the period. Bank of America Corp DE increased its stake in Safeguard Scientifics by 32,504.1% in the first quarter. Bank of America Corp DE now owns 128,786 shares of the asset manager’s stock worth $222,000 after purchasing an additional 128,391 shares during the period. Finally, Legal & General Group Plc increased its stake in Safeguard Scientifics by 5.3% in the second quarter. Legal & General Group Plc now owns 95,711 shares of the asset manager’s stock worth $357,000 after purchasing an additional 4,815 shares during the period. 44.14% of the stock is currently owned by institutional investors.

Safeguard Scientifics Company Profile

(Get Free Report)

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Featured Articles

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.